These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1555891

  • 21. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
    Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S.
    Lab Invest; 1999 Apr; 79(4):407-16. PubMed ID: 10211993
    [Abstract] [Full Text] [Related]

  • 22. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
    Hagelgans A, Menschikowski M, Fuessel S, Nacke B, Arneth BM, Wirth MP, Siegert G.
    Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
    [Abstract] [Full Text] [Related]

  • 23. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.
    Okusa Y, Ichikura T, Mochizuki H, Shinomiya N.
    Int J Oncol; 2000 Nov; 17(5):1001-5. PubMed ID: 11029504
    [Abstract] [Full Text] [Related]

  • 24. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
    Mira-y-Lopez R.
    J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
    [Abstract] [Full Text] [Related]

  • 25. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 26. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 27. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
    Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brünner N.
    Cancer Res; 2001 Jan 15; 61(2):532-7. PubMed ID: 11212246
    [Abstract] [Full Text] [Related]

  • 28. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
    Tao Y, Bazan HE, Bazan NG.
    Invest Ophthalmol Vis Sci; 1996 Sep 15; 37(10):2037-46. PubMed ID: 8814143
    [Abstract] [Full Text] [Related]

  • 29. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
    McGarvey TW, Kariko K, Barnathan ES, Thomas J, Malkowicz SB.
    Int J Oncol; 1998 Jan 15; 12(1):175-80. PubMed ID: 9454902
    [Abstract] [Full Text] [Related]

  • 30. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N.
    Thromb Haemost; 1995 Dec 15; 74(6):1511-5. PubMed ID: 8772229
    [Abstract] [Full Text] [Related]

  • 31. Presence of urokinase plasminogen activator and plasminogen activator inhibitor-1 messenger ribonucleic acids in rat endometrium during decidualization in vivo.
    Wang S, Kennedy TG, Zhang X.
    Biol Reprod; 1996 Sep 15; 55(3):493-7. PubMed ID: 8862764
    [Abstract] [Full Text] [Related]

  • 32. Redundant regulation of urokinase plasminogen activator transcription by the two major isozymes of cAMP-dependent protein kinase.
    Mira-y-Lopez R, Jaramillo S, Waxman S.
    J Biol Chem; 1992 Nov 15; 267(32):23063-8. PubMed ID: 1331075
    [Abstract] [Full Text] [Related]

  • 33. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 15; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 34. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
    Kiguchi T, Niiya K, Shibakura M, Miyazono T, Shinagawa K, Ishimaru F, Kiura K, Ikeda K, Nakata Y, Harada M.
    Int J Cancer; 2001 Sep 15; 93(6):792-7. PubMed ID: 11519039
    [Abstract] [Full Text] [Related]

  • 35. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 15; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 36. A novel model for metastasis suppression involving regulation of nuclear precursor messenger-RNA stability.
    Henderson B, McDonald D, Jones S, Kefford R.
    Int J Oncol; 1995 Feb 15; 6(2):483-6. PubMed ID: 21556563
    [Abstract] [Full Text] [Related]

  • 37. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS.
    Clin Cancer Res; 2001 Aug 15; 7(8):2519-26. PubMed ID: 11489835
    [Abstract] [Full Text] [Related]

  • 38. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
    Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, Postigo A.
    Clin Cancer Res; 2013 Mar 01; 19(5):1071-82. PubMed ID: 23340304
    [Abstract] [Full Text] [Related]

  • 39. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH, Mazar A, Henkin J, Rabbani SA.
    Cancer Res; 1997 Aug 15; 57(16):3585-93. PubMed ID: 9270032
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
    Muñoz-Cánoves P, Miralles F, Baiget M, Félez J.
    Thromb Haemost; 1997 Mar 15; 77(3):526-34. PubMed ID: 9066006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.